WESTMINSTER, Colo.--(BUSINESS WIRE)--Allos Therapeutics, Inc. (NASDAQ: ALTH), a biopharmaceutical company committed to the development and commercialization of innovative anti-cancer therapeutics, today announced that members of the Company’s senior management will present on Monday, February 8, at 2:30 p.m. EST at the 12th Annual BIO CEO & Investor Conference taking place at the Waldorf-Astoria Hotel in New York City.
